Cargando…
Fc-fusion proteins: new developments and future perspectives
Since the first description in 1989 of CD4-Fc-fusion antagonists that inhibit human immune deficiency virus entry into T cells, Fc-fusion proteins have been intensely investigated for their effectiveness to curb a range of pathologies, with several notable recent successes coming to market. These pr...
Autores principales: | Czajkowsky, Daniel M, Hu, Jun, Shao, Zhifeng, Pleass, Richard J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491832/ https://www.ncbi.nlm.nih.gov/pubmed/22837174 http://dx.doi.org/10.1002/emmm.201201379 |
Ejemplares similares
-
Polymeric human Fc-fusion proteins with modified effector functions
por: Mekhaiel, David N. A., et al.
Publicado: (2011) -
Developing the IVIG biomimetic, Hexa-Fc, for drug and vaccine applications
por: Czajkowsky, Daniel M., et al.
Publicado: (2015) -
The therapeutic potential of sialylated Fc domains of human IgG
por: Pleass, Richard J.
Publicado: (2021) -
Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins
por: Liu, Liming
Publicado: (2017) -
Compressive Force Spectroscopy: From Living Cells to Single Proteins
por: Wang, Jiabin, et al.
Publicado: (2018)